These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32128207)

  • 1. Bisoprolol transdermal patch treatment for patients with atrial fibrillation after noncardiac surgery: A single-center retrospective study of 61 patients.
    Yasui T; Oka T; Shioyama W; Oboshi M; Fujita M
    SAGE Open Med; 2020; 8():2050312120907817. PubMed ID: 32128207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing postoperative atrial fibrillation after open-heart surgery using transdermal β
    Yamamoto K; Miwa S; Yamada T; Setozaki S; Hamuro M; Kurokawa S; Enomoto S
    J Cardiothorac Surg; 2023 Apr; 18(1):103. PubMed ID: 37024987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
    Okamura H; Arakawa M; Miyagawa A; Adachi H
    Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1007-1013. PubMed ID: 31049816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    Iwano T; Toda H; Nakamura K; Shimizu K; Ejiri K; Naito Y; Mori H; Masuda T; Miyoshi T; Yoshida M; Hikasa Y; Morimatsu H; Ito H;
    J Cardiol; 2021 Nov; 78(5):349-354. PubMed ID: 34083113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
    Imori Y; Takano H; Mase H; Matsuda J; Sangen H; Izumi Y; Tokita Y; Yamamoto T; Shimizu W
    BMC Cardiovasc Disord; 2019 Dec; 19(1):316. PubMed ID: 31888491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery].
    Yamamoto K; Yamada T; Hamuro M; Kawatou M; Enomoto S
    Kyobu Geka; 2017 Nov; 70(12):971-977. PubMed ID: 29104194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
    Nozaki A; Kobayashi T; Naruhashi K; Okugawa H; Horiuchi N; Nakanishi H; Kobayashi Y; Nakamura S
    Am J Emerg Med; 2021 Jan; 39():146-150. PubMed ID: 33039223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    Yamashita T; Ikeda T; Akita Y
    J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal bisoprolol for prevention of postoperative atrial fibrillation: A systematic review and meta-analysis.
    Kim AG; Banga S; Ang QX; Atti L; Ghnaima H; AlAttal S; Banga P; Wilcox MD
    J Arrhythm; 2024 Jun; 40(3):434-439. PubMed ID: 38939760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
    Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Sano T; Ikeda T
    Clin Exp Hypertens; 2020 Aug; 42(6):539-544. PubMed ID: 32009474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches.
    Sezai A; Sekino H; Taoka M; Osaka S; Tanaka M
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37240955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
    Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
    JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of bisoprolol transdermal patch on early recurrence during the blanking period after atrial fibrillation ablation.
    Suzuki Y; Kuroda M; Fujioka T; Kintsu M; Noda T; Matsumoto A; Kawata M
    J Arrhythm; 2021 Jun; 37(3):607-615. PubMed ID: 34141013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of bisoprolol 8mg transdermal patch at bedtime before coronary computed tomography angiography.
    Yamazaki D; Shimura Y; Enjoji Y; Nishinaga M; Kanmatuse K; Endo M
    J Cardiol; 2020 Apr; 75(4):394-399. PubMed ID: 31627998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    Shinohara M; Fujino T; Koike H; Kitahara K; Kinoshita T; Yuzawa H; Suzuki T; Fukunaga S; Kobayashi K; Aoki J; Tanabe K; Ikeda T
    J Cardiol; 2017 Sep; 70(3):212-219. PubMed ID: 28343798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of beta-blocker therapy in heart failure and atrial fibrillation.
    Fung JW; Yu CM; Kum LC; Yip GW; Sanderson JE
    Card Electrophysiol Rev; 2003 Sep; 7(3):236-42. PubMed ID: 14739721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.